Back to search

Article

Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples

2020-06-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Despite the promising impact of cancer immunotherapy targeting CTLA4 and PD1/PDL1, a large number of cancer patients fail to respond. LAG3 (Lymphocyte Activating 3), also named CD233, is a protein Coding gene served as alternative inhibitory receptors to be targeted in the clinic. The impact of LAG3 on immune cell populations and co-regulation of immune response...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0ab32fb6-ef81-5aa6-8385-bbac80a43b5d
DOI
10.21203/rs.3.rs-36422/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 SamplesDOI 10.21203/rs.3.rs-36422/v1
Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis.Semantic proximity
Prognostic Impact of LAG-3 Expression in Early Breast CancerSemantic proximity
Multomic analysis reveals the potential of LAG3 as a prognostic and immune biomarker and its validation in osteosarcomaSemantic proximity
Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentialsSemantic proximity
Targeting Breast Cancer with a Combination of DNT and LAG3 Checkpoint Blockage and its MechanismSemantic proximity
Understanding LAG-3 SignalingSemantic proximity
The molecular portrait of triple-negative breast cancer: the LAG3 gene single nucleotide polymorphism rs2365094 has no impact on the clinical pictureSemantic proximity
The expression profiles of signature genes from CD103+LAG3+ tumour-infiltrating lymphocyte subsets predict breast cancer survivalSemantic proximity
Gene of the month: lymphocyte-activation gene 3 (LAG-3)Semantic proximity
Analysis of LAGEs Family Gene Signature and Prognostic Relevance in Breast CancerSemantic proximity
LAG ‐3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeuticsSemantic proximity
LAG-3: from molecular functions to clinical applicationsSemantic proximity
Select a neighboring publication to make it the new centre.